Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P155 - ESOC25-1333 MOLECULAR BIOMARKERS IN CEREBRAL AMYLOID ANGIOPATHY WITH AND WITHOUT SYMPTOMATIC INTRACEREBRAL HAEMORRHAGE Benedetta Storti *1 , Alessandro Francia 1,2 , Giulia Marinoni 1 , Benedetta Cefaloni 3 , Nicola Rifino 1 , Giorgio Boncoraglio 1 , Antonio Indaco 4 , Giuseppe Di Fede 4 , Mario Stanziano 5 , Isabella Canavero 1 , Anna Bersano 1 1 Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, 2 Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy, 3 Dipartimento di Matematica, Politecnico di Milano, Milan, Italy, 4 Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, 5 Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy Background and Aims: Cerebral amyloid angiopathy (CAA) typically presents as lobar intracerebral haemorrhage (ICH) or cognitive impairment

This protocol is designed to activate your bodys own repair mechanisms using bioactive peptides providing relief and recovery without steroids or painkillers
It has been found to be a safe and effective treatment for conditions such as allergic rhinitis, sinusitis, and asthma, by reducing inflammation and improving airway function
doi: 10.1111/j.1750-3639.2011.00513.x 86
That series is available for digital download, too: Why Do Vegetarians Have Higher Stroke Risk